Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study.

Bianca Raffaelli,Maria Terhart,Lucas Hendrik Overeem,Jasper Mecklenburg,Lars Neeb,Maureen Steinicke,Uwe Reuter

Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study.

2021

Bianca Raffaelli
Maria Terhart
Lucas Hendrik Overeem
Jasper Mecklenburg
Lars Neeb
Maureen Steinicke
Uwe Reuter

BackgroundNational and international guidelines recommend stopping migraine prophylaxis with CGRP(-receptor) monoclonal antibodies after 6–12 months of successful therapy. In this study, we aimed t...

Keywords:

Discontinuation
longitudinal cohort
Migraine
Medicine
Internal medicine
CGRP receptor
Monoclonal antibody
Calcitonin gene-related peptide
Receptor
Antibody

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations